483 Celgene Jan 2017

483 Celgene Jan 2017

Melissa Roy FDA$119.00 - Available Now

FDA investigators audited the Celgene - Summit, NJ, United States facility and issued inspectional observations (via FDA 483) on 25 Jan 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jan 2017
  • Location: Summit, United States
  • FEI: 3004991673
Add To Cart